Biologic Therapy

Although secukinumab performs similarly to adalimumab in patients with spondyloarthritis who failed their first biological treatment, adalimumab proved superior in those who failed multiple biologics, according to data.

In this video, Diana V. Do, MD, of Byers Eye Institute at Stanford University, discussed the long-term multiple-dose KSI-301 study presented at the virtual American Academy of Ophthalmology annual meeting.

The incidence of COVID-19 infection was low among patients with rheumatic diseases who were using biologic therapies, according to data presented at the ACR Convergence 2020.

Use of biologic therapies in patients with severe, uncontrolled asthma treated by subspecialists in the United States is common, according to data from the real-world, observational CHRONICLE study.

The American College of Rheumatology and 11 other provider and patient groups have called on UnitedHealthcare to cancel its proposed copay accumulator initiative, arguing it would increase financial burdens and limit access to treatments.

Coronary artery plaque lipid-rich necrotic core was associated with psoriasis severity and may be improved with biologic therapy, researchers reported.

There is much to look forward to in the management of psoriatic arthritis, according to a presenter at the 2020 Congress of Clinical Rheumatology-East.

A greater focus on health and wellness could have quantifiable benefits in patients with rheumatologic diseases, according to a presenter at the 2020 Association of Women in Rheumatology National Conference.

August is Psoriasis Awareness Month, a time dedicated to sharing information about psoriasis, its manifestations and its treatments.

Biologic therapies have been proven to significantly change treatment ability and improve the condition of patients with hidradenitis suppurativa, according to a presentation at the Interdisciplinary Autoimmune Summit.